10 Current news of 454 Life Sciences
rssProvides Community Most Complete Assembly to Date
06-16-2011
The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The ...
Sequencing Genomic Regions Associated with Psychiatric Disease
08-03-2009
454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration with Eli Lilly and Company and SeqWright. The goal of this collaboration is to use genomic technologies to identify genetic variants possibly associated with various ...
07-20-2009
For many years, researchers at the Alfred Wegener Institute (AWI) for Polar and Marine Research in Bremerhaven, Germany have been studying polar and marine environments to improve our understanding of ocean-ice-atmosphere interactions and the animal and plant kingdoms of the Arctic and ...
Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
06-13-2008
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: ...
02-11-2008
454 Life Sciences, a part of Roche Applied Science, announced that researchers at Columbia University and Victorian Infectious Disease Reference Laboratory have discovered a new virus that was responsible for the deaths of three transplant recipients. The research explains how the previously ...
01-03-2008
454 Life Sciences, a part of Roche Applied Science, announced that researchers from the Istituto Agrario San Michele all'Adige and Myriad Genetics have used the company's first generation instrument, the Genome Sequencer 20 System, to sequence and assemble the genome of the grape species ...
09-10-2007
454 Life Sciences, a Roche company, announced that researchers at Columbia University, in collaboration with 454, have identified a virus implicated in the deaths of 2.4 million honeybee colonies - tens of billions of bees - using the company's Genome Sequencer(TM) system. The findings ...
The Genome of James Watson is the First to be Sequenced for Less than $1 Million
06-04-2007
454 Life Sciences Corporation, in collaboration with scientists at the Human Genome Sequencing Center, Baylor College of Medicine, announced the completion of a project to sequence the genome of James D. Watson, Ph.D., co-discoverer of the double-helix structure of DNA. The mapping of Dr. ...
04-02-2007
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences' ...
12-09-2005
454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation , and the Genome Sequencing Center (GSC) at Washington University School of Medicine in St. Louis announced a collaborative research plan to sequence disease-causing pathogens and to sequence RNA to analyze gene ...
